Select Medical Holdings CORP 10-Q quarterly reports

Select Medical reports Q1 2026 financial results while progressing toward a $16.50 per share cash acquisition by a consortium led by company leadership.

Select Medical Holdings Corporation reported increased revenue and income from continuing operations for Q3 2025, driven by rehabilitation segments, but faces challenges from new healthcare regulations and ongoing litigation.

Select Medical Holdings Corporation reported increased revenue and income from continuing operations for the second quarter and first half of 2025, driven by strong performance in its Rehabilitation and Outpatient segments, despite a decline in its Critical Illness Recovery Hospital segment and ongoing legal and regulatory uncertainties.

Select Medical Holdings saw a revenue increase in Q1 2025, but net income decreased due to the spin-off of Concentra.

Select Medical Holdings Corporation saw revenue and earnings growth in the third quarter of 2024, while also completing the initial public offering of its Concentra subsidiary.

Select Medical Holdings Corporation reported a slight decrease in income from operations despite a revenue increase in its second quarter, while also completing the initial public offering of its Concentra subsidiary.

Select Medical Holdings Corporation reported a significant increase in revenue and profitability for the first quarter of 2024, primarily driven by strong performance in its critical illness recovery and rehabilitation hospital segments.